Clinical Trial Update: A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 study (BL-M07D1) in patients with solid tumors, including HER2-positive/low-expressing urinary and digestive tract tumors, is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Urinary Tract Cancer

Drugs mentioned

• BL-M07D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Her2-positive/Low-expression Urinary and Digestive Tract Tumors | Phase 1, Phase 2 | Status: RECRUITING